Cargando…

Relationship between Renal Function, Fibrin Clot Properties and Lipoproteins in Anticoagulated Patients with Atrial Fibrillation

Background: Mechanisms by which chronic kidney disease (CKD) influences fibrin clot properties in atrial fibrillation (AF) remain ill-defined. We aimed to investigate the effects of AF and CKD on fibrin clot properties and lipoproteins, and determine the relationship between these factors. Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Wern Yew, Davies, Ian G., Gupta, Dhiraj, Lip, Gregory Y. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496227/ https://www.ncbi.nlm.nih.gov/pubmed/36140371 http://dx.doi.org/10.3390/biomedicines10092270

Ejemplares similares

Relationship between lipoproteins, thrombosis, and atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2021)

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA‐AF Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation
por: Lau, Yee Cheng, et al.
Publicado: (2016)

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
por: Ding, Wern Yew, et al.
Publicado: (2020)

Short‐Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?
por: Ding, Wern Yew, et al.
Publicado: (2019)

Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion
por: Ding, Wern Yew, et al.
Publicado: (2020)

Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS
por: Ding, Wern Yew, et al.
Publicado: (2021)

Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Feasibility of weight loss in obese atrial fibrillation patients attending a specialist arrhythmia clinic and its impact on ablation outcomes
por: Yew Ding, Wern, et al.
Publicado: (2020)

Antithrombotic therapy in chronic liver disease: to clot or not to clot
por: Calvert, Peter, et al.
Publicado: (2021)

Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial
por: Ding, Wern Yew, et al.
Publicado: (2022)

Residual Stroke Risk in Atrial Fibrillation
por: Ding, Wern Yew
Publicado: (2021)

Percutaneous Left Atrial Appendage Occlusion: A View From the UK
por: Ding, Wern Yew, et al.
Publicado: (2020)

Ablation index-guided 50W radiofrequency ablation for left atrial posterior wall isolation in atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

An Antithrombin-Heparin Complex Increases the Anticoagulant Activity of Fibrin Clots
por: Smith, Lesley J., et al.
Publicado: (2008)

Smart Wearables for Cardiac Monitoring—Real-World Use beyond Atrial Fibrillation
por: Duncker, David, et al.
Publicado: (2021)

The neurocognitive effects of atrial fibrillation: benefits of the ABC pathway
por: Calvert, Peter, et al.
Publicado: (2023)

Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry
por: Romiti, Giulio Francesco, et al.
Publicado: (2022)

Frequent premature atrial contractions as a signalling marker of atrial cardiomyopathy, incident atrial fibrillation, and stroke
por: Farinha, José Maria, et al.
Publicado: (2022)

Atrial fibrillation in obesity: Weighing up the evidence for catheter ablation
por: Javed, Saad, et al.
Publicado: (2020)

Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Different Renal Function Equations and Dosing of Direct Oral Anticoagulants in Atrial Fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2022)

Activated Clotting Time Monitoring during Atrial Fibrillation Catheter Ablation: Does the Anticoagulant Matter?
por: Martin, Anne-Céline, et al.
Publicado: (2020)

Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
por: Farinha, José Maria, et al.
Publicado: (2022)

Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer
por: Ording, Anne Gulbech, et al.
Publicado: (2022)

Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project
por: Xiong, Qinmei, et al.
Publicado: (2016)

Practice-derived data on non-vitamin K antagonist oral anticoagulant therapy to complement observations from randomized trials
por: Domek, Magdalena, et al.
Publicado: (2020)

Catheter ablation for atrial fibrillation in heart failure: untying the Gordian knot
por: Javed, Saad, et al.
Publicado: (2021)

Anticoagulation in Elderly Patients With Atrial Fibrillation and Renal Dysfunction
por: Cheung, Christopher C., et al.
Publicado: (2023)

Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
por: Lane, Deirdre A., et al.
Publicado: (2018)

Meniscal Repair With Fibrin Clot Augmentation
por: Chahla, Jorge, et al.
Publicado: (2017)

Fibrin Clot Formation and Lysis in Plasma
por: Larsen, Julie Brogaard, et al.
Publicado: (2020)

Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany
por: Krejczy, Martin, et al.
Publicado: (2015)

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
por: Liang, Hai-Feng, et al.
Publicado: (2019)

Fibrin clot characteristics and anticoagulant response in a SARS‐CoV‐2‐infected endothelial model
por: McCafferty, Conor, et al.
Publicado: (2022)

Percutaneous left atrial appendage occlusion following successful treatment of large bi-atrial thrombi in a patient with atrial fibrillation: a case report
por: Ng, Kim Fong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fk5qh7j81isac3n29lt48vvlf8